Last reviewed · How we verify
NCT06939920
NIV With Airway Washout for Dual Limb Ventilation: Improvement in Minute Ventilation
NA trial testing Non-invasive ventilation mask with airway washout in Respiratory Failure Requiring Non Invasive Ventilation in 20 participants. Not yet recruiting.
1 July 2026
Quick facts
| Lead sponsor | Fisher and Paykel Healthcare |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 1 July 2025 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 July 2026 |
Drugs / interventions tested
- Non-invasive ventilation mask with airway washout
- non-invasive ventilation
Conditions studied
- Respiratory Failure Requiring Non Invasive Ventilation — all drugs for Respiratory Failure Requiring Non Invasive Ventilation →
Sponsor
Fisher and Paykel Healthcare — full company profile →
Who can join
Adults 18 to 90, any sex, with Respiratory Failure Requiring Non Invasive Ventilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, non-randomized, non-blinded, crossover feasibility investigation to assess the safety, usability, and efficacy of the investigational mask in the hospital environment. Eligible patients that are stable in NIV and able to give informed consent will be approached and if they consent the patient will be included in the study. If potential participants decline, normal hospital care will be continued. The enrolled participant will receive NIV on the commercially available Visairo mask for one hour during which their ventilatory parameters will be logged. Then the participant will be switched to the investigational mask for another hour. The ventilator data will be collected for these two hours. At the end of the intervention the participant will be reverted to their original mask. The medical staff will be asked to fill out the case report form pertaining to the function and usability of the investigational mask compared to the conventional mask.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06939920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Fisher and Paykel Healthcare trials
Trials by the same sponsor.
- NCT07484802 — Vela Generation II: Usability and Performance of a Non-Invasive Ventilation Mask. · NA · not yet recruiting
- NCT06738589 — The Inflate Study; Defining the Soft Palate in the Upper Airway Flow Pathway · NA · not yet recruiting
- NCT06670482 — The Effect of Mask Design on Transcutaneous Carbon Dioxide in Healthy Volunteers: A Pilot Clinical Investigation · NA · completed
- NCT06060717 — Evaluation of the F&P Caramel Nasal Mask, US, 2023 · NA · completed
- NCT05422248 — Oxygen Wound Therapy Feasibility Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06939920 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fisher and Paykel Healthcare
- Last refreshed: 22 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06939920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing